logo
Millennials show rising interest in buying homes despite high mortgage rates

Millennials show rising interest in buying homes despite high mortgage rates

Fast Company5 days ago

Millennials (people born between 1981 and 1996) are far more interested in buying homes today than they were just six months ago. That makes the group the only generation whose interest in homeownership has increased since September 2024. However, these same people are tending to put off the investment due to sky-high mortgage rates.
The new data comes from an online survey of 2,230 adults conducted by Realtor.com. Six months ago, 15% of millennials said they were interested in buying a home. Now 23% are interested, according to the latest survey.
Still, that doesn't mean more 29- to 44-year-olds are actually buying homes.
In a press release, Laura Eddy, vice president of research and insights at Realtor.com, noted how the desire to buy a home is being sidelined by soaring mortgage rates. 'Even though we found a change in millennial home-buying intent, the influence of mortgage rates cannot be overstated, with the vast majority of Americans, including millennials, prioritizing lower rates before committing to a purchase.'
Eddy added: 'The lock-in effect is still very much in effect '
The survey also found that most Americans don't have plans to buy a home in the immediate future. Some 69% said they don't intend to go through with a home purchase over the next six months. And one-third of respondents said they have pushed back plans due to those high mortgage rates. But millennials and Gen Zers have delayed their plans at disproportionate rates, with more than half saying they've had to put off their plans to buy a home.
Two-thirds of those surveyed by Realtor.com said mortgage rates have great influence over whether or not they will buy a home. Only 2% said they would even consider a home purchase with mortgage rates exceeding 6%; the threshold appears to be somewhere below 5% for 63% of respondents. (Meanwhile, the national average interest rate on a 30-year fixed mortgage is currently 6.95%, according to Bankrate.)
'Across much of our research we see a trend where potential homebuyers feel stuck when it comes to buying a home due to their current mortgage rate,' Hannah Jones, senior research analyst at Realtor.com, said in the release.
Jones continued, 'Mortgage rates on top of an insufficient supply of budget-friendly homes complicates the affordability picture for many homeowners, especially first-time homebuyers who do not have equity from their existing home to help offset mortgage rates.' Jones added that the experts at Realtor.com believe potential homebuyers are likely to get tired of waiting for change, and out of necessity may go forward with purchases even if they aren't totally satisfied with the rates.
According to recent median home price listings, how much Americans need to earn to afford a home is growing exponentially. As of April 2024, they needed to earn $47,000 more per year to afford a home than they would have just six months prior.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hyundai's CEO Jose Munoz's Vision Of Future Of Mobility & Hyundai
Hyundai's CEO Jose Munoz's Vision Of Future Of Mobility & Hyundai

Forbes

time16 minutes ago

  • Forbes

Hyundai's CEO Jose Munoz's Vision Of Future Of Mobility & Hyundai

I recently had the chance to talk to José Muñoz, the President and CEO of Hyundai Motor Company, and it was a deeply insightful conversation. We spoke at length about the megatrends impacting the future of mobility, his views on the car of the future, and his vision for making Hyundai the leader in both passenger cars and commercial vehicle sales, among other things. Check out the exclusive interview, available on MarketsandMarkets, in which he shares insights on how the automotive giant is managing disruption through dynamic capabilities and strategic diversification. Hyundai CEO Jose Munoz The mobility sector is at an unprecedented crossroads, at the brink of perhaps the perfect storm of technological, social, and economic disruption. In an exclusive conversation, José Muñoz, President and Global CEO of Hyundai Motor Company, provides compelling insights into how one of the world's largest automakers is not just adapting to change but actively shaping the future of mobility. The Megatrends Shaping the Future of Mobility As a true visionary leader, José sees several megatrends converging that will reshape mobility. These include the rapid advancement of AI and digital connectivity—which, as per him, will shape personalised driving and digital living experiences—advanced driver assistance systems, and entirely new mobility services. He also sees social trends like demographics (shifting mobility ownership expectations from Gen Z and millennials) and geopolitics shifting supply chains and manufacturing footprints globally. However, the one trend that he feels is a true game-changer is that the convergence of mobility and energy represents the defining trend of our time. 'Our Executive Chair's vision of 'Progress for Humanity' recognizes that the future of transportation is inseparable from how we generate, store, and use energy', he explains. This philosophy has driven Hyundai Motor Group's bold diversification beyond traditional automotive boundaries into robotics with Boston Dynamics, advanced air mobility through Supernal, and hydrogen infrastructure via HTWO. This integrated approach reflects what Muñoz describes as Hyundai's cultural DNA—balancing ppalli-ppalli (fast-fast) execution with miri-miri (in advance) strategic thinking. The philosophy has enabled Hyundai to respond dynamically to market shifts while keeping its long-term vision intact. The Multi-Energy Reality As the automotive industry struggles to find the right pace of transitioning to electric vehicles, Hyundai has chosen a guarded approach that could yet be ahead of its time. Its hybrid vehicle sales grew 85% in the US market last year, validating its diversified powertrain strategy. 'Our business is ultimately driven by consumer demand, not regulatory mandates', Muñoz emphasizes, revealing Hyundai's plans to double its hybrid electric vehicle portfolio from 7 to 14 models and sell more than 1.3 million hybrid EVs annually by 2028. He explains that the increase in hybrids isn't a retreat from electrification but rather a sophisticated understanding of market realities and consumer demands. Hyundai's manufacturing flexibility allows it to produce multiple powertrains on the same line, providing crucial adaptability as markets evolve at different speeds globally. And while the company's commitment to carbon neutrality by 2045 remains unchanged, its path there considers the diverse needs of consumers across various regions and use cases. A Diversified & Customised Product Portfolio When quizzed about Hyundai's stellar product portfolio, Muñoz outlined a comprehensive approach that balanced stability with opportunity. 'We'll continue to maintain a broad portfolio while making strategic bets in high-growth segments. Our fundamentals are strong—we're building high-quality, safety-focused, eco-friendly vehicles across all major segments, and this diversity gives us stability while allowing us to capture emerging opportunities'. The strategy spans from continued SUV and crossover expansion, where models like the Tucson, Santa Fe, and PALISADE demonstrate market strength, to significant luxury growth through the Genesis brand, which has established itself as a legitimate contender in just ten years with stunning design and exceptional quality. He also has enormous confidence in the three-row IONIQ 9 EV, which he confirms is 'generating tremendous interest', as well as in the electrified Genesis GV70 and other upcoming models. From a product perspective, Muñoz emphasized that their approach transcends traditional categorization: 'Ultimately, our product strategy is guided by customer needs rather than internal preferences. We maintain the flexibility to adjust our portfolio mix as market conditions evolve—a key component of our Dynamic Capabilities approach, with manufacturing processes designed to allow rapid shifts between different models and powertrains based on demand'. Software-Defined Future Though Muñoz agreed that 2025 will be the breakout year for software-defined vehicles, Hyundai is pursuing what Muñoz calls a 'balanced approach'—developing core software capabilities internally while strategically partnering with technology leaders. This hybrid model allows control over customer experience while leveraging external innovation and scale. His strategy rests on three pillars: a unified vehicle architecture enabling over-the-air updates, strengthened internal software capabilities through their Global Software Center, and strategic partnerships like their collaboration with Waymo. This approach recognizes that vehicles require deep hardware-software coordination for safety and reliability. The Consolidation Reality Munoz readily acknowledges that automotive giants like Hyundai have a significant advantage over smaller players when it comes to the high investments required for electrification, software development, and new mobility services. However, he clarifies that Hyundai's approach to consolidation is selective and strategic, focusing more on companies that can help improve Hyundai's core capabilities or give them an edge in adjacent spaces. And this can be readily seen in their acquisition of Boston Dynamics and 42dot, which align with their long-term vision rather than growth for growth's sake. 'Our priority is building on the strong foundation we've established and delivering on our ambitious growth targets for 2030', Muñoz states. Hydrogen: The Long Game Hyundai's forward-thinking approach is prominently seen in its take on hydrogen. While other manufacturers have shifted hydrogen fuel cells to the back burner, Hyundai believes they will be a game-changer in the future and continues to invest heavily in them. In fact, its XCIENT fuel cell trucks are already in production and have proven commercial viability in Switzerland, Korea, and the United States. Muñoz's perspective on hydrogen extends beyond individual vehicles to encompass an entire ecosystem. 'The beauty of hydrogen is that it takes us beyond mobility toward an integrated ecosystem—from production to storage, transport, and delivery', he notes. This vision aligns with the company's broader strategy of addressing both mobility and energy challenges simultaneously. Redefining Growth in a Zero-Sum World The automotive industry is facing what Muñoz describes as four 'innovating to zero' disruptions: zero emissions, zero deaths, zero congestion, and potentially zero growth in traditional vehicle sales. His response to this challenge reveals sophisticated strategic thinking that goes well beyond conventional automotive approaches. Rather than simply pushing more vehicles into saturated markets, Munoz wants to create new value sources through localization, expansion into new markets, development of mobility services, and diversification into adjacent sectors. The company's USD 21 billion investment in US operations over four years, creating 100,000 direct and indirect jobs, exemplifies this approach. 'If we view ourselves as mobility providers rather than just vehicle manufacturers, tremendous growth opportunities remain,' Muñoz says, while explaining that combating 'zero growth' requires companies to fundamentally rethink business models to be successful. A Blueprint for Transformation I came away from our conversation with a portrait of a company that has successfully balanced multiple seemingly contradictory imperatives: maintaining broad product portfolios while making strategic bets, pursuing electrification while expanding hybrid offerings, developing internal capabilities while forming strategic partnerships, and planning for the long term while executing with speed. Whether Hyundai has cracked the code for the future of mobility remains to be seen. Still, there is no denying the fact that it has created a powerful and believable blueprint for manufacturers looking to navigate the coming changes in the automotive industry. By maintaining what Muñoz calls 'dynamic capabilities' or Hyundai's cultural DNA—the ability to respond quickly to market shifts while staying focused on long-term goals—Hyundai has positioned itself to survive the current disruption and emerge as a leader in the mobility ecosystem of the future. As the automotive industry continues its transformation, Hyundai's strategy of diversified resilience combined with focused innovation may well prove to be the winning formula for sustained success in an uncertain future. Read the detailed interview here on Markets and Markets Platform

Does Medicare Cover Cancer Treatment?
Does Medicare Cover Cancer Treatment?

Health Line

time34 minutes ago

  • Health Line

Does Medicare Cover Cancer Treatment?

Key takeaways Original Medicare covers cancer treatment, with Part A covering hospitalization and Part B covering outpatient treatment. Medicare Part C (Medicare Advantage) also offers the same coverage. Medicare Part B pays 80% of the costs for approved cancer treatments after you meet your annual deductible of $257. If you need surgery, Part B will pay for you to consult with a surgical oncologist and get a second opinion from another surgical oncologist. If those two doctors disagree, Part B will also pay for you to seek a third opinion. Part A will cover the costs of the surgery if it is an inpatient procedure. Medicare Part B pays 80% of your care provider's bills for prescribed, approved cancer treatments. You're responsible for 20% of the billed amount until you hit your annual deductible. However, some doctor's visits and procedures must meet unique criteria to be approved by Medicare. For example, if you need surgery, Part B will pay for you to consult with a surgical oncologist and to get a second opinion from another surgical oncologist. If those two doctors disagree, Part B will also pay for you to seek a third opinion. If you're enrolled in Medicare, it covers cancer treatment regardless of your age. Medicare Part D covers prescription drugs that are part of your cancer treatment. This article will answer basic questions about how to find out how much you'll owe for cancer treatment if you have Medicare. If you receive a serious cancer diagnosis, you may want to call the Medicare Health Line at 800-633-4227. This line is available 24/7 and can give you specific answers about anticipating your costs. What does Medicare cover for cancer treatment? Medicare is a federal program in the United States that is governed by several laws. The policies are the 'parts' of Medicare, and they cover different aspects of cancer treatment. Part A Part A covers cancer treatments that you receive as part of an inpatient hospital stay, such as surgery to remove cancerous masses. It also covers skilled nursing facility care, home healthcare (like physical therapy), blood transfusions, costs related to participation in certain cancer-focused clinical studies, and surgically implanted breast prostheses after a mastectomy. Part B Part B covers medically necessary outpatient care, including most types of cancer treatment, such as chemotherapy and radiation. It should also cover doctors' visits, diagnostic testing, outpatient surgery, durable medical equipment, mental health services, and certain preventive care screenings. Part C (Medicare Advantage) Medicare Advantage (Part C) plans are private health insurance plans that offer the same benefits as Original Medicare (Part A and Part B). Some plans may offer additional benefits. Part D Part D covers prescription drugs. Your plan may cover some oral chemotherapy drugs, anti-nausea medications, pain medications, and other medications your doctor prescribes as part of your cancer treatment. Different plans have different restrictions on which drugs they'll cover. How much does Medicare pay for cancer treatments? Before you visit any doctor for your cancer treatment, call their office and ask whether they ' accept assignment.' Doctors who accept assignment take the amount that Medicare pays, as well as your copayment, and consider that a 'full payment' for the services you receive. Doctors who have opted out of Medicare may bill more for your treatment than Medicare will cover, leaving you responsible for the remaining costs along with your copay. Here's what you need to know about Medicare costs. Part A Most people don't have to pay for Part A as long as they have worked and paid taxes in the United States for 10 years or longer. Those who must pay for Part A spend either $285 or $518 per month, depending on their work history. There's a deductible of $1,676, and once you've reached the deductible, Part A covers hospital and postsurgery rehab for 2 months. Beyond that, daily costs apply, and after 100 days, you must cover all expenses. For skilled nursing facility care, your extra daily costs start on day 21. Part B Monthly premiums for Part B start at $185 and increase depending on your income bracket. Once you meet the Part B deductible, which is $257 in 2025, Medicare will pay for 80% of any covered treatment or service. Part C Medicare Part C plans are provided by private insurance companies, and the premiums, deductibles, and coinsurance will vary depending on your specific plan. According to the Centers for Medicare & Medicaid Services, the average monthly premium for Part C plans is $17 in 2025. Part D Part D plans also come from private insurance companies. The national base beneficiary premium is $36.78 in 2025. In addition, the amount you pay out of pocket for prescriptions depends on the drug tier classified within the plan's formulary. The higher the tier, the more expensive the drug will be, even after coverage kicks in. How much will I pay out of pocket for my cancer treatment? The amount you'll pay out of pocket after your Medicare coverage kicks in depends on your plan as well as the type of cancer you have, how aggressive it is, and the treatment type your doctors prescribe. According to a 2021 research review, adults in the United States might pay anywhere from $180 to $2,600 per month for cancer care. And they might spend another $288 per month on cancer medications. If you enroll in Original Medicare, you can also sign up for a Medigap plan, which is another kind of insurance policy that can help cover your share of the cost after Original Medicare covers its share. But you'll have to pay a premium for Medigap, and that cost will vary depending on which of the 10 available plans you choose. According to a 2025 study, people with cancer who sign up for Part C plans have lower out-of-pocket costs than those who have Original Medicare without Medigap, saving a median of $668 and as much as $9,884 at the 95th percentile. However, people enrolled in Original Medicare who had high expenses for their cancer treatment still saved as much as $9,634 in some cases. Frequently asked questions Can Medicare refuse cancer treatment? Generally, Medicare should cover most treatments that are medically necessary. But if your treatment is denied, you can file an appeal. Is cancer insurance worth it with Medicare? Cancer insurance is a private health insurance plan specifically for cancer treatment. It's an additional, non-Medicare policy you can purchase to help you pay for cancer treatment costs. But whether it's worth buying depends on the added cost and the specific coverage of your plan. If you're at a higher risk of developing certain cancers that are associated with high treatment costs, you may want to consider it.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store